Why use Markov simulation models for estimating the effect of cancer screening policies when randomised controlled trials provide better evidence?
Stat Methods Med Res
.
2012 Apr;21(2):217-8.
doi: 10.1177/0962280211407055.
Authors
Alain Braillon
,
Susan Bewley
PMID:
22441731
DOI:
10.1177/0962280211407055
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / diagnosis*
Humans
Markov Chains*
Models, Statistical*